Author： Tavakoli M.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.16, Iss.6, 1999-12, pp. : 627-647
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacoeconomic considerations with statin therapy
By Speidel Katie M Hilleman Daniel E
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. :
Access to resources
Recommend
Pharmacoeconomic Considerations in Treating Actinic Keratosis
PharmacoEconomics, Vol. 27, Iss. 6, 2009-06 ,pp. :
Pharmacoeconomic Considerations in Treating Ovarian Cancer
By Bodurka-Bevers D. Sun C.C. Gershenson D.M.
PharmacoEconomics, Vol. 17, Iss. 2, 2000-02 ,pp. :